The Shared Bulletin Board
Press Releases
-
- Press Releases Infectious Diseases
-
GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB Posted on: July 23, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)
-
- Press Releases Infectious Diseases Research & Development
-
Japan convenes global leaders in malaria research and development to strengthen partnerships for innovative prevention and treatment tools Posted on: July 22, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)
-
- Press Releases Infectious Diseases Drug Development
-
Total Investment of Approx. USD 18 Million in Malaria, Tuberculosis and NTD R&D Projects with Partners Including Shionogi, Eisai, Nagasaki, Ehime and Niigata University Posted on: July 13, 2026 Author: 公益社団法人グローバルヘルス技術振興基金
-
- Press Releases Gene Editing
-
A Divisional Patent of CRISPR-Cas3 Basic Patent Issued in Japan (Patent No. 7886063) Posted on: July 8, 2026 Author: C4U株式会社
-
- Press Releases Infectious Diseases
-
GHIT Fund Kick-Started Emergency Product Development Support for Ebola Disease Outbreak Caused by Bundibugyo Virus Posted on: June 17, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)
-
- Press Releases Gene Editing Drug Discovery
-
C4U Completed the AMED Stage-Gate Evaluation for Stage 2 Posted on: May 29, 2026 Author: C4U株式会社
-
- Press Releases Biotechnology Pharmaceuticals Nucleic Acid Medicine Industry-academia collaboration
-
Crafton Biotechnology Enters into an Agreement for the Manufacturing and Commercialization of a Novel Phosphoramidite Reagent to Enable High‑Purity mRNA Synthesis Posted on: May 18, 2026 Author: Crafton Biotechnology株式会社
-
- Press Releases Gene Editing
-
CRISPR-Cas3 Basic Patent Issued in Europe (European Patent No. 3950942) Posted on: April 30, 2026 Author: C4U Corporation
-
- Press Releases Infectious Diseases Drug Development
-
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects with Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi Posted on: April 23, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)
-
- Press Releases Gene Editing
-
Development of Next-Generation T-Cell Gene Editing Technology Using CRISPR-Cas3 ~ Demonstrating Improved Safety and Potential Application to Allogeneic CAR-T Therapy ~ Posted on: April 21, 2026 Author: C4U Corporation
-
- Press Releases
-
A New Era of “Breathing” Human Lung Organoids — Technology for Reproducing Dynamic Lung Mechanics Published in Biomaterials — Posted on: April 6, 2026 Author: HiLung Inc.
-
- Press Releases Infectious Diseases Research Funding
-
GHIT Fund and Thailand Science Research and Innovation to Strengthen Partnership through Co-funding Initiative Posted on: March 31, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)
This message board is for LINK-J members and partners with LINK-J. Please click here for guidelines, terms and conditions.


